Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Shirley Shapiro Ben David"'
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 3-10 (2023)
Objectives: Data on the economic burden of long COVID are scarce. We aimed to examine the prevalence and medical costs of treating long COVID. Methods: We conducted this historical cohort study using data from patients with COVID-19 among members of
Externí odkaz:
https://doaj.org/article/9353eafeffeb486ea7f5df552bbfe049
Autor:
Shirley Shapiro Ben David, Orna Shamai-Lubovitz, Vered Mourad, Iris Goren, Erica Cohen Iunger, Tamar Alcalay, Angela Irony, Shira Greenfeld, Limor Adler, Amos Cahan
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1355 (2023)
Immunocompromised patients (IPs) are at high risk for infections, some of which are vaccine-preventable. The Israeli Ministry of Health recommends pneumococcal conjugate vaccine 13 (PCV13) and pneumococcal polysaccharide vaccine 23 (PPSV23) for IP, b
Externí odkaz:
https://doaj.org/article/6b72a90c7ae64295a80c62339532de16
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1498 (2023)
Antibiotic overuse and underuse are prevalent in urgent care settings, driven in part by diagnostic uncertainty. A host-based test for distinguishing bacterial and viral infections (MeMed BV) has been clinically validated previously. Here we examined
Externí odkaz:
https://doaj.org/article/105518440c32443d862fb3d119f9e667
Autor:
Miri Mizrahi Reuveni, Jennifer Kertes, Shirley Shapiro Ben David, Arnon Shahar, Naama Shamir-Stein, Keren Rosen, Ori Liran, Mattan Bar-Yishay, Limor Adler
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 767 (2023)
Background: Risk stratification models have been developed to identify patients that are at a higher risk of COVID-19 infection and severe illness. Objectives To develop and implement a scoring tool to identify COVID-19 patients that are at risk for
Externí odkaz:
https://doaj.org/article/ff71f22cdf2e4c61b19a9f8b855e7030
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1654 (2022)
Immune-compromised patients (IPs) are at high risk for infections, some of which are preventable by vaccines. Specific vaccines are recommended for IP; however, the vaccination rate is suboptimal. The aim of this study is to describe the development
Externí odkaz:
https://doaj.org/article/a935f7f94761494f92a4f289e4379b05
Autor:
Ohad Benjamini, Lior Rokach, Gilad Itchaki, Andrei Braester, Lev Shvidel, Neta Goldschmidt, Shirley Shapira, Najib Dally, Abraham Avigdor, Galia Rahav, Yaniv Lustig, Shirley Shapiro Ben David, Riva Fineman, Alona Paz, Osnat Bairey, Aaron Polliack, Ilana Levy, Tamar Tadmor
Publikováno v:
Haematologica, Vol 107, Iss 3 (2021)
Patients with chronic lymphocytic leukemia (CLL) have a suboptimal humoral response to vaccination. Recently, BNT162b2, an mRNA COVID-19 vaccine with a high efficacy of 95% in immunocompetent individuals, was introduced. We investigated the safety an
Externí odkaz:
https://doaj.org/article/e3d25c23a6914bc6bfacef3cffc3c86c
Autor:
Jennifer, Kertes, Shirley, Shapiro Ben David, Avi, Porath, Daniella, Rahamim-Cohen, Naama, Shamir Stein, Anat, Ekka Zohar, Miri, Mizrahi-Reuveni
Publikováno v:
In Preventive Medicine Reports February 2023 31
Autor:
Jennifer Kertes, Shirley Shapiro Ben David, Noya Engel-Zohar, Keren Rosen, Beatriz Hemo, Avner Kantor, Limor Adler, Naama Shamir Stein, Miri Mizrahi Reuveni, Arnon Shahar
Publikováno v:
Clinical Infectious Diseases. 76:e126-e132
Background Intramuscular AZD7442 (tixagevimab–cilgavimab [Evusheld; AstraZeneca]) has been found effective among immunocompromised individuals (ICIs) in reducing SARS-CoV-2 infection and severe disease in ICIs. We evaluated the association between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd39110e6957afc3e43f485e69e2e757
https://doi.org/10.1093/cid/ciac625
https://doi.org/10.1093/cid/ciac625
Autor:
Shirley Shapiro Ben David, Barak Mizrahi, Daniella Rahamim-Cohen, Lia Supino-Rosin, Arnon Shahar, Sharon Hermoni-Alon, Ariela Fremder Sacerdote, Angela Irony, Rachel Lazar, Nir Kalkstein, Yaniv Lustig, Victoria Indenbaum, Daniel Landsberger, Miri Mizrahi-Reuveni, Shirley Shapira
Publikováno v:
Vaccine. 40:4038-4045
As protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaefddb4df15e05e254e989625176716
https://doi.org/10.1016/j.vaccine.2022.05.051
https://doi.org/10.1016/j.vaccine.2022.05.051
The effect of post‐COVID‐19 on gustatory and olfactory function: A preliminary case‐controlled study
Autor:
Dror Livni, Osnat Grinstein‐Koren, Ayelet Zlotogorski‐Hurvitz, Shoshana Reiter, Orit Winocour‐Arias, Jeremy Edel, Yuli Goldman, Marilena Vered, Guy Choshen, Daniella Rahamim‐Cohen, Shirley Shapiro‐Ben David, Ilana Kaplan
Publikováno v:
Oral Diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ece048dd9bd85531d959694f7410d05
https://doi.org/10.1111/odi.14567
https://doi.org/10.1111/odi.14567